The Europe Propylene Glycol Market was valued at USD 1.37 billion in 2024 and is expected to reach USD 1.92 billion by 2034, expanding at a CAGR of 3.5% from 2025 to 2034. With Europe’s long-standing focus on sustainable chemistry, stringent regulations, and innovation-driven manufacturing, propylene glycol has become a critical compound across sectors such as pharmaceuticals,...

The latest business intelligence report released by Polaris Market Research on Electronic Contract Manufacturing and Design Services Market Share, Size, Trends, Industry Analysis Report, By Service (Electronic Design & Engineering, Electronics Assembly, Electronic Manufacturing, and others); By End-Use; By Region; Segment Forecast, 2022 - 2030. It covers the in-depth knowledge of...

The global Electrical Sectionalizer Market is projected to witness significant growth, reaching an estimated valuation of USD 1,581.6 million by 2034, growing at a CAGR of 4.8% during the forecast period (2024–2034). Driven by the rising demand for power distribution automation, aging electrical infrastructure, and increasing investments in smart grid...

The U.S. Propylene Glycol Market, valued at USD 1.07 billion in 2024, is projected to reach USD 1.66 billion by 2034, expanding at a CAGR of 4.5% from 2025 to 2034. This growth is fueled by increasing applications in industries ranging from pharmaceuticals and food processing to automotive, construction, and personal care. Propylene glycol’s adaptability as a solvent, humectant,...

The global propylene glycol market is projected to grow significantly, reaching USD 7.31 billion by 2034, up from USD 4.81 billion in 2024. The market is expected to expand at a steady CAGR of 4.3% during the forecast period (2025–2034). This growth trajectory is attributed to increasing usage across pharmaceuticals, food and beverages, automotive, construction, and personal...

The South Korea blastic plasmacytoid dendritic cell neoplasm (BPDCN) market, valued at USD 42.88 million in 2024, is forecast to expand at a compound annual growth rate (CAGR) of 7.20% between 2025 and 2034, reaching an estimated USD 85.78 million by 2034. Growth will be propelled by improved disease awareness, advancements in targeted therapies, wider diagnostic...